AeroLeads people directory · profile

Jun Ren Email & Phone Number

Senior Scientist at AstraZeneca | Clinical ICC Discovery | Immuno-Oncology, CAR T Cell Therapy, Tumor Microenvironment, Vascular Biology at AstraZeneca
Location: Washington Dc-Baltimore Area, United States 11 work roles 3 schools
1 work email found @dynamiccelltherapies.com 2 phones found area 847 LinkedIn matched
✓ Verified August 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 2 phones

Work email j****@dynamiccelltherapies.com
Direct phone (847) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Senior Scientist at AstraZeneca | Clinical ICC Discovery | Immuno-Oncology, CAR T Cell Therapy, Tumor Microenvironment, Vascular Biology
Location
Washington Dc-Baltimore Area, United States

Who is Jun Ren? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Jun Ren is listed as Senior Scientist at AstraZeneca | Clinical ICC Discovery | Immuno-Oncology, CAR T Cell Therapy, Tumor Microenvironment, Vascular Biology at AstraZeneca, based in Washington Dc-Baltimore Area, United States. AeroLeads shows a work email signal at dynamiccelltherapies.com, phone signal with area code 847, and a matched LinkedIn profile for Jun Ren.

Jun Ren previously worked as Senior Scientist at Astrazeneca and Editorial Board at Translational Oncology (Tranon). Jun Ren holds Postdoctoral Training, Immuno-Oncology, Tumor Microenvironment, Car T-Cel Therapy from Harvard Medical School.

Company email context

Email format at AstraZeneca

This section adds company-level context without repeating Jun Ren's masked contact details.

{first_initial}{last}@dynamiccelltherapies.com
86% confidence

AeroLeads found 1 current-domain work email signal for Jun Ren. Compare company email patterns before reaching out.

Profile bio

About Jun Ren

A driven scientist with a multi-disciplinary background in Immuno-Oncology, Cell therapy, Tumor Microenvironment, and Vascular Biology. Strong scientific, technical, and project management qualifications in the biopharmaceutical industry and academia. Skilled in the design and implementation of research strategy and managing multi-disciplinary research programs for the investigation of cancer therapy. 12+ years experience of in vitro, pre-clinical, and clinical translational research space. Solid track record in project management and demonstrated academic achievement evidenced by publications in high-impact journals. Passionate about exploring novel therapeutic interventions and applying principles established in basic science to making real-life medicine.https://www.cancerresearch.org/scientists/cri-funding-directory/jun-ren-phd

Listed skills include Molecular Biology, Cell Culture, Research, Western Blotting, and 22 others.

Current workplace

Jun Ren's current company

Company context helps verify the profile and gives searchers a useful next step.

AstraZeneca
Astrazeneca
Senior Scientist at AstraZeneca | Clinical ICC Discovery | Immuno-Oncology, CAR T Cell Therapy, Tumor Microenvironment, Vascular Biology
AeroLeads page
11 roles

Jun Ren work experience

A career timeline built from the work history available for this profile.

Senior Scientist

Current

Cambridge, Cambridgeshire, Gb

Clinical ICC Discovery, Oncology R&D

Jan 2024 - Present

Editorial Board

Current
Translational Oncology (Tranon)
Jul 2020 - Present

Review Editor

Current
Frontiers In Immunology - Cancer Immunity And Immunotherapy
Jul 2020 - Present

Review Editor

Current
Frontiers In Oncology - Cancer Molecular Targets And Therapeutics
Jun 2019 - Present

Scientific Director

Watertown, Ma, Us

Develop next-generation CAR T Cell therapy for patients with liquid and solid tumors, allowing for multiplexing, titration, and modularity to deliver superior safety and efficacy to cancer patients.

Aug 2020 - Jan 2024

Cancer Research Institute (Cri) - Dr. Keith Landesman Memorial Research Fellow

Boston, Massachusetts, Us

• Improving the delivery and efficacy of CAR T cells in pediatric and adult brain tumors.• Reprogramming the tumor microenvironment to improve immunotherapy of glioblastoma.

Jul 2019 - Aug 2020

American Heart Association (Aha) Research Fellow

Madison, Wi, Us

Research Interests:• Pathogenesis of restenosis and aneurysm• Inflammatory chemokines involved intimal hyperplasia and aneurysm• Cross talk among smooth muscle cells, endothelial cells, adventitial cells, and circulating progenitor cells• Endothelial progenitor cells and circulating angiogenic cells • Gene (viral and non-viral) and Cell therapyResearch Projects:My projects focus on elucidating the mechanism underlying vascular smooth muscle cells-mediated injury response. Specifically, my study is to understand how stressed vascular smooth muscle cells cross talk with vascular wall cells and circulating cells in order to orchestrate vascular injury response using angioplasty models, and develope gene and cell therapies to speed up recovery of blood vessels.

Jul 2015 - Jun 2016

Research Assistant

Madison, Wi, Us

My major research has been focused on the pathogenesis of vascular diseases including intimal hyperplasia and aneurysm. Specifically, I focus on chemokines expression, cross-talk among smooth muscle cells, endothelial cells, adventitial cells, and circulating progenitor cells during neointima formation in vitro and in vivo. In addition, I also put my effort to develop gene therapies against intimal hyperplasia using polyelectrolyte multilayers/DNA-coated catheter balloons, and cell therapy for a speedy recovery of injured blood vessels.

Jan 2011 - Jun 2015

Business Development Specialist

Minneapolis, Mn, Us

Medtronic Cardiovascular Group

Sep 2010 - Dec 2010

Research Assistant

Guangdong, Cn

Research projects: • Regulation of the Legionella pneumophila Dps homolog by iron and involved during multiple stress tolerance.• The role of effector protein (LegK3) of Legionella pneumophila between pathogen-host interaction.• Characterization of the LysR-type transcriptional regulator LpvcR of Legionella pneumophila.

Sep 2007 - Aug 2010
3 education records

Jun Ren education

Postdoctoral Training, Immuno-Oncology, Tumor Microenvironment, Car T-Cel Therapy

Harvard Medical School

Doctor Of Philosophy (Phd), Vascular Biology

University Of Wisconsin-Madison

Master Of Science (Ms), Medical Microbiology And Bacteriology

Sun Yat-Sen University
FAQ

Frequently asked questions about Jun Ren

Quick answers generated from the profile data available on this page.

What company does Jun Ren work for?

Jun Ren works for AstraZeneca.

What is Jun Ren's role at AstraZeneca?

Jun Ren is listed as Senior Scientist at AstraZeneca | Clinical ICC Discovery | Immuno-Oncology, CAR T Cell Therapy, Tumor Microenvironment, Vascular Biology at AstraZeneca.

What is Jun Ren's email address?

AeroLeads has found 1 work email signal at @dynamiccelltherapies.com for Jun Ren at AstraZeneca.

What is Jun Ren's phone number?

AeroLeads has found 2 phone signal(s) with area code 847 for Jun Ren at AstraZeneca.

Where is Jun Ren based?

Jun Ren is based in Washington Dc-Baltimore Area, United States while working with AstraZeneca.

What companies has Jun Ren worked for?

Jun Ren has worked for Astrazeneca, Translational Oncology (Tranon), Frontiers In Immunology - Cancer Immunity And Immunotherapy, Frontiers In Oncology - Cancer Molecular Targets And Therapeutics, and Dynamic Cell Therapies, Inc..

How can I contact Jun Ren?

You can use AeroLeads to view verified contact signals for Jun Ren at AstraZeneca, including work email, phone, and LinkedIn data when available.

What schools did Jun Ren attend?

Jun Ren holds Postdoctoral Training, Immuno-Oncology, Tumor Microenvironment, Car T-Cel Therapy from Harvard Medical School.

What skills is Jun Ren known for?

Jun Ren is listed with skills including Molecular Biology, Cell Culture, Research, Western Blotting, Science, Biochemistry, Higher Education, and Life Sciences.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.